Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiyanping injection for acute bronchitis in children
NCT04926506Phase 4Unknown
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Start
- Oct 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of Xiyanping injection + antibiotic in acute bronchitis (2 arms), sponsored by Jiangxi Qingfeng Pharmaceutical Co. Ltd. Primary endpoint: Total clinical effective rate at Day 7. Status: unknown.
02
Drugs
Xiyanping injection + antibiotic
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on NCT04926506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04926506.